Drug–drug interactions (DDIs) may lead to adverse effects and potentially result in drug
withdrawal from the market. Predicting DDIs during drug development would help reduce …

The prediction of drug-target interactions (DTIs) is of extraordinary significance to modern
drug discovery in terms of suggesting new drug candidates and repositioning old drugs. …

Using replica exchange molecular dynamics simulations and the implicit solvent model we
probed binding of ibuprofen to Aβ 10–40 monomers and amyloid fibrils. We found that the …

Using replica exchange molecular dynamics simulations and an all-atom implicit solvent
model, we probed the energetics of Aβ 10–40 fibril growth. The analysis of the interactions …

Although the oligomers formed by Aβ peptides appear to be the primary cytotoxic species in
Alzheimer's disease, detailed information about their structures appears to be lacking. In this …

Replica exchange molecular dynamics and all‐atom implicit solvent model are used to compute
the structural propensities in Aβ monomers, dimers, and Aβ peptides bound to the edge …

We examine the effect of deletion of the amino-terminal (residues 1−9) on the structure and
energetics of Aβ 1−40 peptides. To this end, we use replica exchange molecular dynamics to …

Drug repurposing requires distinguishing established drug class targets from novel
molecule-specific mechanisms and rapidly derisking their therapeutic potential in a time-critical …

Nonsteroidal anti‐inflammatory drugs are considered as potential therapeutic agents against
Alzheimer's disease. Using replica exchange molecular dynamics and atomistic implicit …

Using implicit solvent molecular dynamics and replica exchange simulations, we study the
impact of ibuprofen on the growth of wild-type Aβ fibrils. We show that binding of ibuprofen to …